We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Genetic Links Found to Chronic Lymphocytic Leukemia

By LabMedica International staff writers
Posted on 18 Dec 2013
Genome-wide association studies (GWAS) of chronic lymphocytic leukemia (CLL) have shown that common genetic variation contributes to the heritable risk of CLL.

Four new regions of the genome linked with an increase in susceptibility to CLL have been identified, which suggest that this common type of blood cancer may develop partly as a result of faults in telomeres. More...


Scientists at The Institute of Cancer Research (Sutton, Surrey, UK) and their international collaborators analyzed the genomes of 1,739 patients with CLL and 5,199 healthy adults. The study linked four single nucleotide polymorphisms (SNPs) with susceptibility to CLL. They conducted an independent primary scan of CLL and performed a genome-wide meta-analysis with a previously published GWAS followed by analysis of the top SNPs in two separate case-control series.

In the primary scan they genotyped 1,271 cases using the Omni Express BeadChip (Illumina, San Diego, CA, USA). The total number of risk variants for CLL identified is now 30, with the genetic factors newly identified by the study found around a set of genes responsible for the function of telomeres.

CLL is the most common form of leukemia in western countries, with over 3,000 people diagnosed in the UK each year. It is a slowly progressing and currently incurable form of cancer that affects blood-producing cells in the bone marrow. Close relatives of CLL patients are at eight times higher risk of being diagnosed than the general population.

Richard Houlston, MD, PhD, a professor of Molecular and Population Genetics at The Institute of Cancer Research, said: “We are starting to complete the picture of how CLL development is dictated by mutations in regions of the genome connected to specific aspects of DNA repair. These genetic factors explain a significant proportion of inherited cases of CLL.” The study was published on December 1, 2013, in the journal Nature Genetics.

Related Links:

The Institute of Cancer Research
Illumina



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.